Malaria Vaccine Booster Study
Malaria Prevention in Children
SponsorGSK
4,500Enrollment Target
25Trial Sites
5Countries
June 2028Est. Completion
About This Trial
Evaluating optimal booster schedules for sustained malaria protection in endemic regions.
Primary Endpoints
- Clinical malaria incidence
- Antibody persistence
Latest Update
January 2026
WHO prequalification received. Over 18 million doses shipped to endemic countries.